Cyclacillin Production Cost Reports

The report provides a detailed analysis essential for establishing a cyclacillin production plant. It encompasses all critical aspects necessary for cyclacillin production, including the cost of cyclacillin production, cyclacillin plant cost, cyclacillin production costs, and the overall cyclacillin production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a cyclacillin production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Cyclacillin is a semi-synthetic antibiotic compound that is mainly used in the pharmaceutical and healthcare industries. It belongs to the penicillin group and is primarily used to treat bacterial infections caused by susceptible microorganisms. It is widely used to treat infections of the respiratory tract, urinary tract, and skin caused by susceptible bacteria.

It works by interfering with the formation of bacterial cell walls, which helps stop the growth and spread of infection. It serves as a major component in the formulation of oral antibiotic medications for infections related to the respiratory tract, urinary tract, etc. It is also used as an ingredient in pediatric formulations for ear infections and throat issues. Moreover, it is also used as a reference drug in medical research and quality testing during the development of other antibiotic drugs.

The demand for cyclacillin is primarily driven by its application as an antibacterial drug that targets bacterial infections, which contributes to its market expansion. Its application as an antibiotic to combat susceptible gram-positive and gram-negative bacteria, especially in respiratory tract infections, skin conditions, and urinary tract disorders, also drives its demand in the pharmaceutical industry.

Its usage in the treatment of conditions like pneumonia and tonsillitis caused by organisms such as Streptococcus or Staphylococcus species further strengthens its demand in the medical and healthcare sectors. Its oral bioavailability and improved stability make it a preferred choice in outpatient treatments, which supports its demand within the pharmaceutical and healthcare sectors. Industrial cyclacillin procurement is influenced by several factors, including the cost and accessibility of raw materials such as penicillin derivatives, regulatory approvals, and production compliance. Moreover, supplier dependability, developments in antibiotic formulation technologies, environmental safety norms, and global antimicrobial resistance strategies also continue to shape procurement processes worldwide.

Raw Material for Cyclacillin Production

According to the cyclacillin production plant project report, the major raw materials for cyclacillin production include 6-aminopenicillanic acid, methylene chloride, triethylamine, N,N-dimethylaniline, trimethylchlorosilane, and 1-amino-1-cyclohexanecarboxylic acid chloride.

Production Process of Cyclacillin

The extensive cyclacillin production cost report consists of the following industrial production process:

1. Production from 6-aminopenicillanic Acid: The production process of cyclacillin starts by activating 6-aminopenicillanic acid in methylene chloride with triethylamine and N,N-dimethylaniline under reflux. Then, trimethylchlorosilane is added at low temperature and refluxed to protect the amino group, followed by cooling and addition of 1-amino-1-cyclohexanecarboxylic acid chloride at an even lower temperature. Further, the mixture is quenched in cold water, filtered, adjusted to pH 5.4 with dilute sodium hydroxide, and stirred overnight to crystallise the product. Finally, the obtained product is filtered, washed with water and acetone, and dried to obtain cyclacillin as the desired product.

Cyclacillin is a semi-synthetic aminopenicillin antibiotic and a cyclohexylamido analogue of penicillanic acid. It appears as a white to off-white crystalline powder with a molecular weight of 341.43 g/mol. The molecular formula of the compound is C15H23N3O4S. The compound is marketed under various trade names, including Cyclapen, Vastcillin, and Calthor. It is characterised by its beta-lactam structure and is more resistant to beta-lactamase hydrolysis than ampicillin, which exhibits much higher oral bioavailability. It demonstrates a broad spectrum of antibacterial activity against various Gram-positive and some Gram-negative bacteria, including Staphylococcus, Streptococcus, Escherichia coli, Klebsiella, Proteus, and Haemophilus influenzae. The melting point of the compound is around 182-183 degree Celsius, and its boiling point is 649.6 degree Celsius. The compound should be stored in a dry, dark environment at 0–4 degree Celsius for short-term storage or at -20 degree Celsius for long-term storage. As with other penicillin antibiotics, side effects may include allergic reactions and gastrointestinal disturbances, and the compound should be used judiciously to minimise the development of antibiotic resistance.